MEG3 and gastric cancer: In gastric cancer cell (AGS) models, overexpression of MEG3 inhibited epithelial-mesenchymal transition (EMT) by decreasing MMP-3 and MMP-9 levels and thereby inhibiting cell migration (Xu et al., 2018a).